Flipper consistently presents himself as more knowledgeable than others, yet repeatedly avoids engaging with counterarguments when his claims are challenged. Instead of reassessing his views, discussions tend to devolve into dismissive or hostile responses.
His track record over the past years shows little accuracy on substantive issues. While he once showed some ability in interpreting trial statistics, his analysis has been persistently weak in other areas particularly regarding MHRA and NICE regulatory frameworks.
Market Data 
Markets 
AI
